Fowl Cholera in Poultry: Pathogenesis, Clinical Signs, Diagnosis, and Control

Introduction

Fowl cholera is a highly contagious bacterial disease of domestic and wild birds caused by Pasteurella multocida [1, 2]. The disease affects chickens, turkeys, ducks, geese, and numerous other avian species, often resulting in acute septicemia with high morbidity and mortality [3, 4]. Chronic forms also occur, characterized by localized infections such as wattles, sinuses, and joints [5]. The economic impact on commercial poultry operations is substantial, with losses from mortality, reduced egg production, and treatment costs [6, 7]. This article provides an exhaustive review of the pathogenesis, clinical signs, diagnostic approaches, and control measures for fowl cholera, with emphasis on molecular and immunological advances.

Etiology

Pasteurella multocida is a Gram-negative, non-motile, facultatively anaerobic coccobacillus belonging to the family Pasteurellaceae [1, 8]. The bacterium is classified into five capsular serogroups (A, B, D, E, F) and 16 somatic lipopolysaccharide (LPS) serotypes [9, 8]. Avian isolates predominantly belong to serogroups A and F, with serotypes A:1, A:3, and A:4 commonly associated with outbreaks [9, 10]. The complete genome sequences of multiple avian P. multocida strains have been elucidated, revealing a core genome of approximately 2.3 Mb and a pan-genome rich in virulence-associated genes [1, 8]. Key virulence factors include the polysaccharide capsule, LPS, filamentous hemagglutinin, and the Pasteurella multocida toxin (PMT) [11, 12]. The hyaluronic acid capsule, encoded by the hya operon, is critical for resistance to phagocytosis and complement-mediated killing [13, 12]. The LPS outer core locus exhibits phase variation, contributing to immune evasion and persistence in carrier birds [14].

Epidemiology

Fowl cholera occurs worldwide, with sporadic outbreaks and enzootic patterns influenced by management practices, biosecurity, and environmental factors [15, 16]. Transmission occurs horizontally via respiratory aerosols, ingestion of contaminated feed or water, and through fomites [6, 5]. Carrier birds, including recovered poultry and wild waterfowl, serve as reservoirs for P. multocida [16, 14]. Stressors such as overcrowding, poor ventilation, nutritional deficiencies, and concurrent infections predispose flocks to clinical disease [3, 7]. Land cover and proximity to water bodies have been associated with increased outbreak risk, likely due to environmental persistence and wild bird contact [15]. In Bangladesh, genomic profiling of isolates from ISA Brown chickens revealed multidrug-resistant strains with diverse sequence types [1, 17]. Similarly, Australian poultry farms harbor widespread ST20 clones that also infect wild waterbirds [16]. Coinfections with Mycoplasma gallisepticum exacerbate mortality in turkey flocks [3].

Pathogenesis

Following inhalation or ingestion, P. multocida colonizes the upper respiratory tract and invades the mucosal epithelium [18, 13]. The capsule and LPS facilitate evasion of host defenses, allowing bacteria to enter the bloodstream and cause septicemia [11, 12]. The stringent response, mediated by (p)ppGpp, negatively regulates capsule production, suggesting a trade-off between persistence and virulence [12]. The filamentous hemagglutinin B1 (FhaB1) gene, although present in many strains, is not essential for pathogenesis in turkey poults [18]. In contrast, the hyaluronan synthase HyaD contributes to virulence by promoting capsule synthesis and resisting phagocytosis [13]. PMT, a potent mitogenic toxin, activates intracellular signaling pathways (e.g., G proteins, MAP kinases) leading to cellular proliferation and immune dysregulation [11]. The toxin is not produced by all avian isolates, but its presence correlates with increased pathogenicity in some strains [11]. Phase variation in LPS glycosyltransferase genes enables P. multocida to alter surface antigenicity, facilitating chronic carriage and recurrent outbreaks [14]. The bacterium can survive within macrophages and evade killing, contributing to systemic dissemination [13, 12].

Clinical Signs

The clinical presentation of fowl cholera varies with the virulence of the strain, host species, and route of exposure [4, 5]. In acute cases, birds die suddenly without premonitory signs, often with high mortality (up to 100% in susceptible flocks) [4, 9]. Peracute disease is characterized by fever, depression, anorexia, cyanosis of the comb and wattles, and mucoid discharge from the mouth and nostrils [5, 7]. In subacute and chronic forms, localized infections manifest as swollen wattles (wattle edema), sinusitis, conjunctivitis, arthritis, and torticollis due to middle ear infection [5, 19]. Respiratory signs include dyspnea and rales, often exacerbated by concurrent mycoplasmosis [3]. Egg production drops sharply in laying flocks [7]. The incubation period ranges from 12 to 48 hours under natural conditions [6].

Pathology

Gross lesions in acute fowl cholera include generalized congestion, petechial hemorrhages on serosal surfaces (especially epicardium and abdominal fat), and enlarged, friable liver and spleen [4, 5]. The liver often exhibits multiple pale necrotic foci (1-2 mm in diameter), a hallmark of the disease [9, 5]. Pneumonia and airsacculitis are common, particularly in turkeys [3, 9]. In chronic cases, caseous exudate may be found in the wattles, sinuses, joints, and oviduct [5, 19]. Histopathological examination reveals fibrinoid necrosis of blood vessels, multifocal hepatic necrosis, and infiltration of heterophils and macrophages in affected tissues [4, 20]. The bacterium can be visualized in tissue sections using Gram or Giemsa stains [5].

Diagnosis

Definitive diagnosis of fowl cholera relies on isolation and identification of P. multocida from clinical specimens (blood, liver, spleen, bone marrow, or wattle exudate) [21, 5]. Samples are cultured on blood agar or MacConkey agar (the latter is selective for Gram-negative bacteria) and incubated at 37°C for 24-48 hours [21, 5]. Colonies are small, grayish, and non-hemolytic; they produce a characteristic "mousy" odor [5]. Biochemical tests (oxidase positive, catalase positive, indole positive, urease negative) confirm the genus [21, 5]. Capsular serotyping is performed using multiplex PCR targeting capsular genes [9, 10]. Molecular detection methods include conventional PCR targeting the kmt1 gene (species-specific) and the hyaD-hyaC capsule genes [22, 23]. Loop-mediated isothermal amplification (LAMP) assays offer rapid, field-deployable detection with sensitivity comparable to PCR [23]. Real-time PCR and high-throughput sequencing provide genotypic characterization and antimicrobial resistance profiling [1, 2, 8]. Serological diagnosis using indirect ELISA detects antibodies against P. multocida and is useful for flock-level surveillance [24, 25]. In-house ELISA kits have been developed and optimized for chicken sera [24]. The diagnostic workflow is summarized in Figure 1.

flowchart TD
    A[Clinical suspicion: sudden death, cyanosis, wattle edema], > B[Postmortem examination: petechiae, hepatic necrosis]
    B, > C[Sample collection: liver, spleen, blood, bone marrow]
    C, > D[Gram stain: Gram-negative coccobacilli]
    C, > E[Culture on blood agar: 37°C, 24-48h]
    E, > F[Biochemical identification: oxidase+, catalase+, indole+]
    F, > G[PCR: kmt1 gene, capsular typing]
    G, > H[Serotyping: multiplex PCR for capsular groups A, B, D, E, F]
    G, > I[Antimicrobial susceptibility testing: disk diffusion or MIC]
    C, > J[Molecular detection: LAMP or real-time PCR]
    J, > K[Genomic characterization: WGS for virulence and resistance genes]
    H, > L[Confirm diagnosis: fowl cholera]
    I, > L
    K, > L

Figure 1. Diagnostic workflow for fowl cholera in poultry.

Treatment and Control

Antimicrobial therapy is the primary intervention for acute outbreaks, but resistance is widespread [2, 21, 22]. Commonly used antibiotics include tetracyclines, fluoroquinolones, sulfonamides, and penicillins [21, 5]. Antibiogram profiling is essential to guide therapy, as multidrug-resistant strains are increasingly reported [2, 22, 17]. In Ethiopia, isolates from breeder chickens showed high resistance to tetracycline and ampicillin [21]. Chinese avian isolates exhibited resistance to sulfonamides and streptomycin, with resistance genes carried on mobile genetic elements [2]. Probiotics have been investigated as alternatives; a multi-strain probiotic reduced fowl cholera mortality in broilers [26]. Plant extracts, such as wild Egyptian artichoke, demonstrate in vitro antibacterial activity against P. multocida [27]. Biosecurity measures include all-in-all-out management, disinfection of premises, rodent and wild bird control, and quarantine of newly introduced birds [6, 7]. Vaccination is a cornerstone of long-term control.

Vaccination

Both inactivated (bacterin) and live attenuated vaccines are available for fowl cholera [28, 29, 9]. Bacterins are typically bivalent or multivalent, containing multiple serotypes, and are administered parenterally [9, 30]. Adjuvants such as oil emulsions, aluminum hydroxide, and hydrogel formulations enhance immunogenicity [29, 30]. A gel 01 hydrogel inactivated vaccine induced protective immunity in chickens [29]. Gamma-irradiated vaccines, formulated with various adjuvants, elicited strong antibody and cytokine responses in chickens [25, 31]. Live attenuated strains, such as the duck-derived PMZ8 strain, show promise due to their ability to induce mucosal and systemic immunity [28]. Subunit vaccines targeting lipoprotein E (PlpE) have been developed; inclusion of a signal sequence or flagellin adjuvant improves immunogenicity [32, 33]. A truncated LPS outer core mutant provided protection in ducks [34]. Vaccination strategies should be tailored to the circulating serotypes and production system [9, 7]. In endemic areas, autogenous vaccines prepared from local isolates are often used [9].

Fowl Cholera Bacterial and Fowl Cholera in Hindi

The term "fowl cholera bacterial" emphasizes the bacterial etiology of the disease, distinguishing it from viral or parasitic causes of similar clinical signs. In Hindi, fowl cholera is referred to as "मुर्गी हैजा" (murgee haija) or "फाउल हैजा" (phaul haija). Awareness of the disease in regional languages is important for extension services and farmer education in South Asia, where poultry production is expanding rapidly [1, 17]. Diagnostic capacity and antimicrobial stewardship are critical in these regions to mitigate the impact of fowl cholera.

Conclusion

Fowl cholera remains a significant threat to global poultry health, driven by the genetic diversity and antimicrobial resistance of P. multocida. Advances in genomics, molecular diagnostics, and vaccinology have improved our understanding of pathogenesis and provided new tools for control. Integrated management combining biosecurity, vaccination, and prudent antimicrobial use is essential to reduce disease burden. Future research should focus on cross-protective vaccines, rapid point-of-care diagnostics, and alternative therapies to combat resistant strains.

References

[1] Islam MA, Haque ME, Iftehimul M, et al. Genomic profiling of Pasteurella multocida strains isolated from ISA Brown (Gallus gallus domesticus) in Bangladesh. Microbiol Resour Announc. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41920836/

[2] Miao F, Dai B, Li Z, et al. Antimicrobial resistance and genomic characteristics of avian Pasteurella multocida. Poult Sci. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41637789/

[3] Gornatti-Churria CD, Jerry C, Ramsubeik S, et al. High mortality in a commercial turkey flock associated with coinfection by Pasteurella multocida and Mycoplasmoides (Mycoplasma) gallisepticum. J Vet Diagn Invest. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/40996859/

[4] Miller I, Jerry C, Nguyen V, et al. 100% Mortality in Commercial Slow-Growing Broiler Chickens with Acute Fowl Cholera. Avian Dis. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40643942/

[5] Geda AM. Fowl Cholera in Chickens: Current Trends in Diagnosis and Phenotypic Drug Resistance in Gondar City, Ethiopia. Vet Med Int. 2024. URL: https://pubmed.ncbi.nlm.nih.gov/39669206/

[6] Malek A. Dynamics of cholera transmission in poultry farm: insights from a compartmental model and control strategies. Br Poult Sci. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/40960429/

[7] Fasina YO, Suarez DL, Ritter GD, et al. Unraveling frontiers in poultry health (part 1) - Mitigating economically important viral and bacterial diseases in commercial Chicken and Turkey production. Poult Sci. 2024. URL: https://pubmed.ncbi.nlm.nih.gov/38417326/

[8] Hashish A, Johnson TJ, Ghanem M, et al. Complete genome sequences of eight Pasteurella multocida isolates representing all lipopolysaccharide outer core loci. Microbiol Resour Announc. 2024. URL: https://pubmed.ncbi.nlm.nih.gov/39365089/

[9] Semmate N, Bamouh Z, Elkarhat Z, et al. Isolation and Characterization of Pasteurella multocida A from an Outbreak in Turkeys in Morocco and Vaccine Preparation and Evaluation. Avian Dis. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40643939/

[10] Xiao J, Li Y, Hu Z, et al. Characterization of Pasteurella multocida isolated from ducks in China from 2017 to 2019. Microb Pathog. 2021. URL: https://pubmed.ncbi.nlm.nih.gov/34534643/

[11] Kubatzky KF. Pasteurella multocida toxin - lessons learned from a mitogenic toxin. Front Immunol. 2022. URL: https://pubmed.ncbi.nlm.nih.gov/36591313/

[12] Smallman TR, Williams GC, Harper M, et al. Genome-Wide Investigation of Pasteurella multocida Identifies the Stringent Response as a Negative Regulator of Hyaluronic Acid Capsule Production. Microbiol Spectr. 2022. URL: https://pubmed.ncbi.nlm.nih.gov/35404102/

[13] Gao P, Wang L, Wang S, et al. The activity of hyaD contributed to the virulence of avian Pasteurella multocida. Microb Pathog. 2024. URL: https://pubmed.ncbi.nlm.nih.gov/38960217/

[14] Omaleki L, Blackall PJ, Cuddihy T, et al. Phase variation in the glycosyltransferase genes of Pasteurella multocida associated with outbreaks of fowl cholera on free-range layer farms. Microb Genom. 2022. URL: https://pubmed.ncbi.nlm.nih.gov/35266868/

[15] Ouyang L, Campler MR, Wong S, et al. Exploring the Impact of Land Cover on the Occurrence of Ornithobacteriosis and Fowl Cholera: A Case-Case Study. Animals (Basel). 2025. URL: https://pubmed.ncbi.nlm.nih.gov/39943166/

[16] Allen JL, Bushell RN, Noormohammadi AH, et al. Pasteurella multocida ST20 is widespread in Australian poultry farms and may infect wild waterbirds. Vet Microbiol. 2024. URL: https://pubmed.ncbi.nlm.nih.gov/38228079/

[17] Saha O, Islam MR, Rahman MS, et al. First report from Bangladesh on genetic diversity of multidrug-resistant Pasteurella multocida type B:2 in fowl cholera. Vet World. 2021. URL: https://pubmed.ncbi.nlm.nih.gov/34840474/

[18] Dassanayake RP, Briggs RE, Kaplan BS, et al. Pasteurella multocida filamentous hemagglutinin B1 (fhaB1) gene is not involved with avian fowl cholera pathogenesis in turkey poults. BMC Vet Res. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40140814/

[19] Kannaki TR, Priyanka E, Haunshi S. Research Note: Disease tolerance/resistance and host immune response to experimental infection with Pasteurella multocida A:1 isolate in Indian native Nicobari chicken breed. Poult Sci. 2021. URL: https://pubmed.ncbi.nlm.nih.gov/34217907/

[20] Shalaby AG, Bakry NR, El-Demerdash AS. Virulence attitude estimation of Pasteurella multocida isolates in embryonated chicken eggs. Arch Microbiol. 2021. URL: https://pubmed.ncbi.nlm.nih.gov/34554268/

[21] Geda AM, Wendimu A, Lulie S, et al. Molecular Detection and Antibiogram Profiling of Pasteurella multocida Isolated From Breeder Chickens Suspected of Fowl Cholera in Gondar City, Ethiopia. Int J Microbiol. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40297765/

[22] El-Tarabili RM, Enany ME, Alenzi AM, et al. Unveiling resistance patterns, kmt1 sequence analyses, virulence traits, and antibiotic resistance genes of multidrug-resistant Pasteurella multocida retrieved from poultry and rabbits. Sci Rep. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/39948418/

[23] Poussard M, Pant SD, Huang J, et al. Comparative evaluation of PCR and loop-mediated isothermal amplification (LAMP) assays for detecting Pasteurella multocida in poultry. N Z Vet J. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/39448061/

[24] Beyene D, Shite A, Getachew B. Development and optimization of in-house made indirect ELISA kit for the detection of antibodies against Pasteurella multocida in chicken. BMC Immunol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41724974/

[25] Belay E, Bitew M, Ibrahim SM, et al. Gamma-irradiated fowl cholera vaccines formulated with different adjuvants induced antibody response and cytokine expression in chickens. Front Immunol. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40103817/

[26] Reuben RC, Sarkar SL, Ibnat H, et al. Novel multi-strain probiotics reduces Pasteurella multocida induced fowl cholera mortality in broilers. Sci Rep. 2021. URL: https://pubmed.ncbi.nlm.nih.gov/33903662/ *** Disclaimer: This article is for educational and informational purposes only. It is not intended to substitute for professional veterinary advice, diagnosis, treatment, or regulatory guidance. Always consult a licensed veterinarian or qualified specialist regarding animal health, disease diagnosis, and therapeutic decisions.

[27] Wahdan A, Elsebai MF, Elhaig MM, et al. Innovative use of wild Egyptian artichoke extract to control fowl cholera in vitro. Vet World. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40182829/

[28] Ji X, Meng Y, Yang H, et al. Attenuation mechanisms and vaccine potential of the serial passage-derived Pasteurella multocida strain PMZ8 in ducks. Poult Sci. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41747463/

[29] Chen J, Sun Y, Hu Y, et al. Evaluation of the immunoprotective effect of gel 01 hydrogel inactivated vaccine against Pasteurella multocida infection in chickens. Microb Pathog. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40934985/

[30] Ghadimipour R, Ghorbanpoor M, Gharibi D, et al. Effects of Selected Adjuvants on Immunogenicity and Protectivity of Pasteurella multocida Bacterin Vaccine in Chickens. Arch Razi Inst. 2021. URL: https://pubmed.ncbi.nlm.nih.gov/35096310/

[31] Dessalegn B, Bitew M, Asfaw D, et al. Gamma-Irradiated Fowl Cholera Mucosal Vaccine: Potential Vaccine Candidate for Safe and Effective Immunization of Chicken Against Fowl Cholera. Front Immunol. 2021. URL: https://pubmed.ncbi.nlm.nih.gov/34917086/

[32] Chung YC, Cheng LT, Chu CY, et al. Flagellin Enhances the Immunogenicity of Pasteurella multocida Lipoprotein E Subunit Vaccine. Avian Dis. 2024. URL: https://pubmed.ncbi.nlm.nih.gov/39400212/

[33] Cheng LT, Chu CY, Vu-Khac H, et al. Signal sequence contributes to the immunogenicity of Pasteurella multocida lipoprotein E. Poult Sci. 2023. URL: https://pubmed.ncbi.nlm.nih.gov/36423524/

[34] Zhao X, Yang F, Shen H, et al. Immunogenicity and protection of a Pasteurella multocida strain with a truncated lipopolysaccharide outer core in ducks. Vet Res. 2022. URL: https://pubmed.ncbi.nlm.nih.gov/35236414/

[35] Bathobakae L, Cho H, Philip S, et al. Friend Turned Foe: Pasteurella multocida Bacteremia Following a Scratch by an Adopted Pekin Duck. J Investig Med High Impact Case Rep. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40110910/